News
SRBT
0.134
NaN%
--
Weekly Report: what happened at SRBT last week (0908-0912)?
Weekly Report · 09/15 10:36
Weekly Report: what happened at SRBT last week (0901-0905)?
Weekly Report · 09/08 10:38
Weekly Report: what happened at SRBT last week (0825-0829)?
Weekly Report · 09/01 10:34
Weekly Report: what happened at SRBT last week (0818-0822)?
Weekly Report · 08/25 10:42
Weekly Report: what happened at SRBT last week (0811-0815)?
Weekly Report · 08/18 10:36
Weekly Report: what happened at SRBT last week (0804-0808)?
Weekly Report · 08/11 10:42
Weekly Report: what happened at SRBT last week (0728-0801)?
Weekly Report · 08/04 10:44
Weekly Report: what happened at SRBT last week (0721-0725)?
Weekly Report · 07/28 10:45
Weekly Report: what happened at SRBT last week (0714-0718)?
Weekly Report · 07/21 10:37
Weekly Report: what happened at SRBT last week (0707-0711)?
Weekly Report · 07/14 10:44
Weekly Report: what happened at SRBT last week (0630-0704)?
Weekly Report · 07/07 10:38
Weekly Report: what happened at SRBT last week (0623-0627)?
Weekly Report · 06/30 10:42
Weekly Report: what happened at SRBT last week (0616-0620)?
Weekly Report · 06/23 10:37
Weekly Report: what happened at SRBT last week (0609-0613)?
Weekly Report · 06/16 10:42
Weekly Report: what happened at SRBT last week (0602-0606)?
Weekly Report · 06/09 10:43
Weekly Report: what happened at SRBT last week (0526-0530)?
Weekly Report · 06/02 10:49
Weekly Report: what happened at SRBT last week (0519-0523)?
Weekly Report · 05/26 10:48
Weekly Report: what happened at SRBT last week (0512-0516)?
Weekly Report · 05/19 10:41
Weekly Report: what happened at SRBT last week (0505-0509)?
Weekly Report · 05/12 10:42
Weekly Report: what happened at SRBT last week (0428-0502)?
Weekly Report · 05/05 10:43
More
Webull provides a variety of real-time SRBT stock news. You can receive the latest news about Shanrong Biotech through multiple platforms. This information may help you make smarter investment decisions.
About SRBT
Shanrong Biotechnology Corp. is a holding company for select biotechnology, health, and wellness operations. The Company owns and operates three patents: Long-lasting preparation of long-term stable intravenous melatonin injectable addressing sepsis, bacterial pathologies, and other inflammatory pathology; new melatonin formulations for the treatment of chemotherapy-resistant tumors addressing cancer (head and neck, prostate, breast, ovarian, melanoma), and injectable melatonin composition for the treatment of viral diseases addressing coronavirus disease of 2019 (COVID-19) and other viral diseases.